New drugs for the treatment of tuberculosis

New drugs for the treatment of tuberculosis

Bibliographic Details
Main Author:	A. Diacon
Format:	Article
Language:	English
Published:	Elsevier 2014-04-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971214006365

Similar Items

A CLINICAL CASE OF EFFECTIVE TREATMENT OF EXTENSIVE DRUG RESISTANCE TUBERCULOSIS WITH NEW ANTI-TUBERCULOSIS DRUGS
by: M. V. Pаvlovа, et al.
Published: (2018-01-01)

Naphthoquinone Derivatives as Scaffold to Develop New Drugs for Tuberculosis Treatment
by: Priscila C. B. Halicki, et al.
Published: (2018-04-01)

TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE USING NEW ANTI-TUBERCULOSIS DRUGS IN THE CIVILIAN COMMUNITY OF ARKHANGELSK REGION
by: Anastasiya I. Gayda, et al.
Published: (2018-08-01)

Treatment of drug-resistant tuberculosis
by: Pinto LM, et al.
Published: (2011-07-01)

New drugs for treating tuberculosis!!!
by: Kaushik Saha
Published: (2015-01-01)

Drug treatment for patient with tuberculosis in the National Tuberculosis Programme
by: Naresh Pratap K.C.
Published: (2013-05-01)

What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
by: Surendra K Sharma, et al.
Published: (2019-01-01)

Challenges in the development of drugs for the treatment of tuberculosis
by: Adeeb Shehzad, et al.

Challenges in the development of drugs for the treatment of tuberculosis
by: Adeeb Shehzad, et al.
Published: (2013-02-01)

Challenges in the development of drugs for the treatment of tuberculosis
by: Adeeb Shehzad, et al.
Published: (2013-01-01)

Ototoxicity of aminoglycoside drugs in tuberculosis treatment
by: G. R. Voogt, et al.
Published: (1996-12-01)

Impact of drug resistance on the tuberculosis treatment outcome
by: E. Lesnic, et al.
Published: (2017-03-01)

The problem of neurotoxicity of drugs in the treatment of tuberculosis patients
by: G. N. Mozhokina, et al.
Published: (2020-11-01)

ECONOMIC FEASIBILITY OF NEW CHEMOTHERAPY REGIMENS FOR TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2018-07-01)

TREATMENT EFFICIENCY OF DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
by: M. V. Pavlova, et al.
Published: (2016-08-01)

New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
by: Brigden G, et al.
Published: (2015-10-01)

ADVERSE SIDE EFFECTS OF TUBERCULOSIS ETIOTROPIC TREATMENT REGIMENS CONTAINING THE NEW ANTI-TUBERCULOSIS DRUG OF SQ109
by: S. E. Borisov
Published: (2018-08-01)

Adverse drug reactions of anti-tuberculosis treatment among children with tuberculosis
by: Madeeha Laghari, et al.
Published: (2020-01-01)

Surgical Treatment of Complications of Pulmonary Tuberculosis, including Drug-Resistant Tuberculosis
by: Rajhmun Madansein, et al.
Published: (2015-03-01)

New drugs and perspectives for new anti-tuberculosis regimens
by: S. Tiberi, et al.
Published: (2018-03-01)

Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis
by: Diana Machado, et al.
Published: (2018-07-01)

Impact of diabetes mellitus on tuberculosis drug resistance in new cases of tuberculosis
by: Parvaneh Baghaei, et al.
Published: (2015-01-01)

Treatment of Drug-Resistant Tuberculosis: Current Status
by: Rajendra Prasad, et al.
Published: (2021-04-01)

The role of delamanid in the treatment of drug-resistant tuberculosis
by: Lewis JM, et al.
Published: (2015-05-01)

Drug-resistant tuberculosis: emerging treatment options
by: Adhvaryu MR, et al.
Published: (2011-12-01)

Therapeutic Drug Monitoring in the Treatment of Active Tuberculosis
by: Aylin Babalik, et al.
Published: (2011-01-01)

Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives
by: Erica Lessem, et al.
Published: (2015-03-01)

Heterogeneity of Mycobacterium tuberculosis drug resistance in respect of pharmacokinetics of anti-tuberculosis drugs as a basis for individual treatment regimen
by: S. A. Popov, et al.
Published: (2015-04-01)

Efficacy and safety of novel and repurposed drugs for the treatment of drug-resistant tuberculosis
by: Olayanju, Olatunde
Published: (2020)

Multi drug and other forms of drug resistant tuberculosis are uncommon among treatment naïve tuberculosis patients in Tanzania.
by: Tumaini J Nagu, et al.
Published: (2015-01-01)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
by: Denise Rossato Silva, et al.

Self-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatment.
by: Timothy F Brewer, et al.
Published: (2011-01-01)

Preclinical and clinical trials of the new tuberculosis drug perchlozon
by: P K Yablonskiy, et al.
Published: (2016-03-01)

Drug-Resistant Mycobacterium tuberculosis among New Tuberculosis Patients, Yangon, Myanmar
by: Sabai Phyu, et al.
Published: (2003-02-01)

Analysis of treatment outcomes for destructive pulmonary tuberculosis in patients with multiple drug resistance of M. tuberculosis
by: Yu. A. Sheyfer, et al.
Published: (2020-11-01)

Delamanid expanded access novel treatment of drug resistant tuberculosis
by: Rustomjee R, et al.
Published: (2015-10-01)

Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance
by: Radha Gopalaswamy, et al.
Published: (2021-05-01)

Tuberculosis evolution and treatment outcome in drug addicted patients
by: Evelina Lesnic, et al.
Published: (2018-10-01)

Management of tuberculosis: From drug treatment to control program
by: Gopi C Khilnani, et al.
Published: (2011-01-01)

Undernutrition and Treatment Success in Drug-Resistant Tuberculosis in Uganda
by: Baluku JB, et al.
Published: (2021-09-01)

Cannot write session to /tmp/vufind_sessions/sess_l2hmthhhbno7ijm50fh97rqtf2